Ansing, Aglenn E.

HRN: 21-64-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CEFUROXIME 1.5GM (VIAL)
07/23/2022
07/30/2022
IV
1.5g
Q8
CAP-MR
Waiting Final Action 
07/23/2022
AZITHROMYCIN 500MG TABLET (TAB)
07/23/2022
07/29/2022
PO
500mg
OD
CAP-MR; COVID-19 Pneumonia
Waiting Final Action 
07/24/2022
CEFTRIAXONE 1G (VIAL)
07/24/2022
07/30/2022
IV
2g
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: